Porous polyethylene implant manufacturer Poriferous has received a patent from the US Patent and Trademark Office (USPTO) for its DuraBloc technology.

The technology is part of the company’s portfolio of developments in the field of craniomaxillofacial implants.

It offers a dual-sided design and features a nonporous, smooth underside combined with a porous polyethylene structure on the remaining sides of the implant.

Poriferous noted that this design allows for fibrovascular ingrowth while reducing tissue adhesion, with the aim of supporting easier removal.